VintaBio, a biotech manufacturer specializing in high-yield, high-purity viral vectors for gene therapy, today presented data further demonstrating the advantages and productivity of its proprietary ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and ...

Ring Therapeutics says it has demonstrated the ability to encapsidate nucleic acid payloads through in vitro assembly.

VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present transformative data on its ...

Andelyn Biosciences Inc. successfully manufactured a novel viral vector gene therapy to treat a baby with the ultra-rare ...

demonstrate that VintaProcess™ enables enrichment of full capsids at harvest by extending viral vector production using a novel perfusion process, offering a major step forward in simplifying ...